Medicaid Drug Rebate Program -- Manufacturers and supporting regulation at 42 CFR 447.534

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
8182	Medicaid Drug Rebate Program -- Manufacturers and supporting regulation at 42 CFR 447.534	Form	Migrated

ICR Details

OMB Control No: 0938-0578	ICR Reference No: 200312-0938-008
Status: Historical Active	Previous ICR Reference No: 200306-0938-004
Agency/Subagency: HHS/CMS	Agency Tracking No:
Title: Medicaid Drug Rebate Program -- Manufacturers and supporting regulation at 42 CFR 447.534
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Emergency	Approval Requested By: 12/31/2003
OIRA Conclusion Action: Approved without change	Conclusion Date: 12/30/2003
	Date Received in OIRA: 12/29/2003
Terms of Clearance: This information collection request is approved on an emergency basis for a period of 6 months, consistent with CMS' Medicaid Drug Rebate Program interim final rule. During this time period, CMS will solicit comment on the additional recordkeeping require- ments and will take these public comments into account in the development of a final recordkeeping timeframe for the Drug Rebate Program.

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2004	07/31/2004	08/31/2006
Responses	2,280	0	2,280
Time Burden (Hours)	54,780	0	54,780
Cost Burden (Dollars)	983,000	0	983,000

---

Abstract: Section 1927 requires drug manufacturers to enter into and have in effect a rebate agreement with the Federal Government for Stat States to receive funding for drugs dispensed to Medicaid recipients.

Emergency Justfication:

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Medicaid Drug Rebate Program -- Manufacturers and supporting regulation at 42 CFR 447.534	CMS-367, CMS-367A, CMS-367C

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	2,280	2,280	0	0	0	0
Annual Time Burden (Hours)	54,780	54,780	0	0	0	0
Annual Cost Burden (Dollars)	983,000	983,000	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/29/2003

---